Related Experiment Videos
Longitudinal study on latex sensitization in children with spina bifida
R Cremer1, A Hoppe, U Kleine-Diepenbruck
1Children's Hospital, Pediatric Clinic, Cologne, Germany.
Summary
Implementing latex prophylaxis significantly impacts latex sensitization in spina bifida patients. Strict adherence can prevent new allergies and reduce existing ones, even during surgery.
Area of Science:
- Immunology
- Allergy and Immunology
- Clinical Medicine
Background:
- The progression of latex sensitization is infrequently documented.
- Limited research exists on the impact of prophylaxis in occupational settings, particularly for healthcare workers.
- Patients with spina bifida represent a high-risk group for latex sensitization.
Purpose of the Study:
- To investigate the efficacy of latex prophylaxis in patients with spina bifida.
- To evaluate the long-term course of latex sensitization in this high-risk population.
- To determine the influence of prophylactic measures on IgE antibody levels against latex.
Main Methods:
- A follow-up study was conducted on 67 patients with spina bifida.
- Serum IgE antibodies against latex and inhalative allergens were measured using FEIA.
- Patients were reevaluated 0.6 to 4.1 years after initial assessment.
- Prophylactic measures were implemented, including patient education and a latex-free surgical environment.
Main Results:
- 37% of patients did not develop latex antibodies during the follow-up period.
- 27% of patients showed decreasing IgE antibody levels, with 12% becoming non-detectable.
- 19% experienced an increase in latex sensitization, with 6% newly sensitized.
- 9% exhibited no significant change in latex antibody levels.
Conclusions:
- Surgery performed without strict latex prophylaxis is a primary driver of new sensitization and exacerbation of existing latex allergy.
- Prophylactic interventions can effectively reduce mild latex sensitization to undetectable antibody levels.
- Consistent latex prophylaxis allows for the safe surgical management of symptomatic patients, mitigating allergic complications and antibody level increases.